Myeloma Paper of the Day, June 9th, suggested by Robert Orlowski

Robert Orlowski shared on X:

“Myeloma Paper of the Day: Progression of MGUS to multiple myeloma may be associated with up-regulated EIF2 signaling, DNA repair, enhanced translational quality control and overall loss of surface antigens.”

Source: Robert Orlowski/X

Progression of monoclonal gammopathy of undetermined significance to multiple myeloma is associated with enhanced translational quality control and overall loss of surface antigens

Authors: Sigrid Ravn Berg, Aida Dikic, Animesh Sharma, Lars Hagen, Cathrine Broberg Vågbø, Alexey Zatula, Kristine Misund, Anders Waage, and Geir Slupphaug.

Other posts featuring Robert Orlowski on OncoDaily.

Robert Orlowski holds multiple positions at The University of Texas MD Anderson Cancer Center, including Chairman, Ad Interim Director of Myeloma, and Professor of Medicine in the Departments of Lymphoma/Myeloma and Experimental Therapeutics within the Division of Cancer Medicine.

Additionally, he chairs the SWOG Barlogie/Salmon Myeloma Committee, which is part of the National Clinical Trials Network, dedicated to advancing new therapies and understanding the biology of myeloma.